Omega Funds

Activity from announced rounds

Activity in this selectionHealthtech
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$123M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1

By primary sector

Healthtech2

By country

Spain1
United States1

Rounds

2 in this selection
Anaconda Biomed

Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.

$56MSeries C
Lead
Spiro Medical

Develops a Pulmonary Neuromodulation System for asthma treatment

$67MSeries A
Role not disclosed